Better funding plans vital for success

Innovation can help biotech companies cut costs, boost profits

The bull run that has defined the global biotechnology space is not showing any signs of slowing down, but if countries in Asia plan to take advantage of the growth of the space in the long run they might have to develop better funding and innovation strategies.

Since 2009, biopharma companies that were once the smaller cousins of giant global pharmaceutical companies have seen their value, by market capitalization, escalate.